Nomegestrol / chlormadinone - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Nomegestrol and chlormadinone containing medicines: Measures to minimise the risk of meningioma

Key facts

• Active substance:
  • Nomegestrol
  • chlormadinone
• Procedure number:
  EMEA/H/A-31/1510
• Regulatory outcome:
  Variation
• DHPC type:
  • Adverse event
  • Referral - Article 31
• Referral name:
  Nomegestrol and chlormadinone
• Human ATC codes:
  G03
• Dissemination date:
  08/11/2022